Three numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 2 other studies
the abstract, start to end
… (RD) of 0.91% (odds ratio (OR) of 0.86, 95% CI 0.80 to 0.92; eight …
… or no effect on mortality (RD 0.03%, OR 1.02, 95% CI 0.91 to 1.14; 12 …
… risk of any adverse events (RD 1.54%, OR 1.08, 95% CI 1.04 to 1.12; 13 …
← favours treatmentfavours comparator →
could be chanceLipids
OR 0.860.80–0.92
All-cause mortality
OR 1.020.91–1.14
Adverse events & safety
OR 1.081.04–1.12
PCSK9 inhibitorsOther lipid agentsLipidsAll-cause mortalityAdverse events & safety
PCSK9 inhibitors × adverse events & safetyharms?mixed
unlikelylikely
0.00not counted
PCSK9 inhibitors × all-cause mortalityhelps?replicated
unlikelylikely
1.00not counted
← favours treatmentfavours comparator →
1 / 5